Delivery of Placenta-Derived Mesenchymal Stem Cells Ameliorates Ischemia Induced Limb Injury by Immunomodulation
Background: Peripheral artery disease (PAD) is a major health burden in the world. Stem cell-based therapy has emerged as an attractive treatment option in regenerative medicine. In this study, we sought to test the hypothesis that stem cell-based therapy can ameliorate ischemia induced limb injury....
Main Authors: | Bo Zhang, T.M. Ayodele Adesanya, Li Zhang, Nanzi Xie, Zhishui Chen, Minghuan Fu, Jie Zhang, Jian Zhang, Tao Tan, Ahmet Kilic, Zhihong Li, Hua Zhu, Xiaoyun Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2014-11-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/366395 |
Similar Items
-
Neonatal acute limb ischemia
by: Rebecca Bonny-Obro, et al.
Published: (2021-03-01) -
Molecular action mechanisms of the immunomodulators
by: Belteghi, C.
Published: (2008-06-01) -
Topical immunomodulators in dermatology
by: Khandpur Sujay, et al.
Published: (2004-04-01) -
Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators
by: Kordzadeh-Kermani E, et al.
Published: (2020-02-01) -
Immunomodulating effect of nanoparticles used in nanomedicine
by: Gómez-Gallego, Diana Maryory, et al.
Published: (2016-10-01)